1 – 10 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
(
- Contribution to journal › Article
-
Mark
Targeting TUBG1 in RB1-negative tumors
2025) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39(5).(
- Contribution to journal › Article
- 2024
-
Mark
Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
(
- Contribution to journal › Article
-
Mark
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography
(
- Contribution to journal › Article
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
(
- Contribution to journal › Article
-
Mark
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
(
- Contribution to journal › Article
-
Mark
3D cultivation of non-small-cell lung cancer cell lines using four different methods
(
- Contribution to journal › Article
-
Mark
TPP1 is associated with risk of advanced precursors and cervical cancer survival
(
- Contribution to journal › Article
- 2023
-
Mark
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
(
- Contribution to journal › Article